Zum Inhalt
Erschienen in:

01.06.2015 | main topic

Drug safety aspects of herbal medicinal products

verfasst von: Dr. T. Wegener, B. Deitelhoff, A. Silber-Mankowsky

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 11-12/2015

Einloggen, um Zugang zu erhalten

Summary

There are numerous statements in the literature suggesting that the safety of herbal products or herbal medicinal products is inadequately considered. Despite the presence of risk, the potential is commonly underestimated as herbals are considered to be natural substances. It is necessary to consider the different categories of herbal products in the market. On one hand there are authorised herbal medicinal products (HMPs) which have adhered to the requirements to present data on quality, efficacy and safety. On the other hand there are products falling outside the use of marketing authorisations as for remedies. In the European Union (EU), HMPs are subject to an ambitious and comprehensive risk management system as for chemically defined drugs, which react effectively to risk concerns with scientific methods, as has been shown in the past. The established methods of pharmacovigilance and risk management favour the authorisation of herbal preparations for medicinal purposes as proprietary medicinal drugs.
Literatur
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Metadaten
Titel
Drug safety aspects of herbal medicinal products
verfasst von
Dr. T. Wegener
B. Deitelhoff
A. Silber-Mankowsky
Publikationsdatum
01.06.2015
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 11-12/2015
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-015-0370-9